Coronary Stents Market By Type (Drug-eluting Stents, Bare-metal Coronary Stents, Bioabsorbable Stents), By Biomaterial (Metallic biomaterials, Polymers biomaterials, Natural biomaterials), By End User (Hospitals, Ambulatory Surgical Centers, Other): Global Opportunity Analysis and Industry Forecast, 2020-2030
The global coronary stents market was valued at $8,814.9 million in 2020 and is projected to reach $15,421.06 million by 2030, registering a CAGR of 6.0% from 2021 to 2030.
Coronary stent is a small expandable tube, which is used for the treatment of narrowed or blocked coronary arteries and reduce chest pain (angina). Patients with coronary artery disease (CAD) are treated using these stents. These stents are also known as cardiac stents and comprise metallic mesh. These coronary stents are implanted in narrowed coronary artery during percutaneous coronary intervention (PCI).
The factor that drives growth of coronary stents market include increase in incidence of CAD, rise in innovation in coronary stents, and surge in improved clinical outcomes, due to stenting.
In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes and obesity and improved insurance & reimbursement scenario supplement the global coronary stents market growth.
Conversely, availability of alternative methods for coronary heart disease treatment and high cost of treatment associated with coronary stents hinder the growth of the market during forecast years. However, increase in adoption of coronary stents in developing countries is expected to offer lucrative growth opportunities for the market during the forecast period.
The global coronary stents market is segmented on the basis of product, biomaterial, end user, and region. Depending on product, it is classified into drug-eluting stent, bare-metal stent, and bioabsorbable vascular stent. On the basis of biomaterial, it is categorized into metallic, polymeric, and natural biomaterial. According to end user, it is divided into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key market players profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Becton Dickinson and Company, Microport Scientific Corporation, Terumo Corporation, Medtronic plc., Biotronik SE & Co. KG, Biosensors International Group, Ltd., and Elixir Medical Corporation.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the coronary stents market analysis from 2020 to 2030 to identify the prevailing coronary stents market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the coronary stents market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global coronary stents market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
Drug-eluting Stents
Bare-metal Coronary Stents
Bioabsorbable Stents
By Biomaterial
Metallic biomaterials
Polymers biomaterials
Natural biomaterials
By End User
Hospitals
Ambulatory Surgical Centers
Other
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of LAMEA
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of LAMEA
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Abbott Laboratories
B. Braun Melsungen AG
Biotronik Se & Co. KG
Boston Scientific Corporation
Becton, Dickinson and Company
Elixir Medical Corporation
Medtronic PLC.
Microport Scientific Corporation
Biosensors International Group
Terumo Corporation
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: CORONARY STENTS MARKET, BY TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Drug-eluting Stents
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Bare-metal Coronary Stents
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Bioabsorbable Stents
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- CHAPTER 5: CORONARY STENTS MARKET, BY BIOMATERIAL
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Metallic biomaterials
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Polymers biomaterials
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Natural biomaterials
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: CORONARY STENTS MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Ambulatory Surgical Centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Other
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: CORONARY STENTS MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Type
- 7.2.3 North America Market size and forecast, by Biomaterial
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Type
- 7.2.5.1.2 Market size and forecast, by Biomaterial
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Type
- 7.2.5.2.2 Market size and forecast, by Biomaterial
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Type
- 7.2.5.3.2 Market size and forecast, by Biomaterial
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Type
- 7.3.3 Europe Market size and forecast, by Biomaterial
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Type
- 7.3.5.1.2 Market size and forecast, by Biomaterial
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Type
- 7.3.5.2.2 Market size and forecast, by Biomaterial
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 U.K.
- 7.3.5.3.1 Market size and forecast, by Type
- 7.3.5.3.2 Market size and forecast, by Biomaterial
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Type
- 7.3.5.4.2 Market size and forecast, by Biomaterial
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Type
- 7.3.5.5.2 Market size and forecast, by Biomaterial
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of LAMEA
- 7.3.5.6.1 Market size and forecast, by Type
- 7.3.5.6.2 Market size and forecast, by Biomaterial
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Biomaterial
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 China
- 7.4.5.1.1 Market size and forecast, by Type
- 7.4.5.1.2 Market size and forecast, by Biomaterial
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 Japan
- 7.4.5.2.1 Market size and forecast, by Type
- 7.4.5.2.2 Market size and forecast, by Biomaterial
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Type
- 7.4.5.3.2 Market size and forecast, by Biomaterial
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 Australia
- 7.4.5.4.1 Market size and forecast, by Type
- 7.4.5.4.2 Market size and forecast, by Biomaterial
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Type
- 7.4.5.5.2 Market size and forecast, by Biomaterial
- 7.4.5.5.3 Market size and forecast, by End User
- 7.4.5.6 Rest of LAMEA
- 7.4.5.6.1 Market size and forecast, by Type
- 7.4.5.6.2 Market size and forecast, by Biomaterial
- 7.4.5.6.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Type
- 7.5.3 LAMEA Market size and forecast, by Biomaterial
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Type
- 7.5.5.1.2 Market size and forecast, by Biomaterial
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Type
- 7.5.5.2.2 Market size and forecast, by Biomaterial
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Type
- 7.5.5.3.2 Market size and forecast, by Biomaterial
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Type
- 7.5.5.4.2 Market size and forecast, by Biomaterial
- 7.5.5.4.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Abbott Laboratories
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 B. Braun Melsungen AG
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Biotronik Se & Co. KG
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Boston Scientific Corporation
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Becton, Dickinson and Company
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Elixir Medical Corporation
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Medtronic PLC.
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Microport Scientific Corporation
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Biosensors International Group
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Terumo Corporation
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 2. CORONARY STENTS MARKET REVENUE, FOR DRUG-ELUTING STENTS, BY REGION , 2020-2030,($MILLION)
- TABLE 3. CORONARY STENTS MARKET DRUG-ELUTING STENTS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 4. CORONARY STENTS MARKET REVENUE, FOR BARE-METAL CORONARY STENTS, BY REGION , 2020-2030,($MILLION)
- TABLE 5. CORONARY STENTS MARKET BARE-METAL CORONARY STENTS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 6. CORONARY STENTS MARKET REVENUE, FOR BIOABSORBABLE STENTS, BY REGION , 2020-2030,($MILLION)
- TABLE 7. CORONARY STENTS MARKET BIOABSORBABLE STENTS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 8. GLOBAL CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
- TABLE 9. CORONARY STENTS MARKET REVENUE, FOR METALLIC BIOMATERIALS, BY REGION , 2020-2030,($MILLION)
- TABLE 10. CORONARY STENTS MARKET METALLIC BIOMATERIALS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 11. CORONARY STENTS MARKET REVENUE, FOR POLYMERS BIOMATERIALS, BY REGION , 2020-2030,($MILLION)
- TABLE 12. CORONARY STENTS MARKET POLYMERS BIOMATERIALS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 13. CORONARY STENTS MARKET REVENUE, FOR NATURAL BIOMATERIALS, BY REGION , 2020-2030,($MILLION)
- TABLE 14. CORONARY STENTS MARKET NATURAL BIOMATERIALS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 15. GLOBAL CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 16. CORONARY STENTS MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION)
- TABLE 17. CORONARY STENTS MARKET HOSPITALS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 18. CORONARY STENTS MARKET REVENUE, FOR AMBULATORY SURGICAL CENTERS, BY REGION , 2020-2030,($MILLION)
- TABLE 19. CORONARY STENTS MARKET AMBULATORY SURGICAL CENTERS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 20. CORONARY STENTS MARKET REVENUE, FOR OTHER, BY REGION , 2020-2030,($MILLION)
- TABLE 21. CORONARY STENTS MARKET OTHER BY COUNTRY, 2020-2030,($MILLION)
- TABLE 22. CORONARY STENTS MARKET, BY REGION, 2020-2030,($MILLION)
- TABLE 23. NORTH AMERICA CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 24. NORTH AMERICA CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
- TABLE 25. NORTH AMERICA CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 26. NORTH AMERICA CORONARY STENTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 27. U.S. CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 28. U.S. CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 29. U.S. CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 30. CANADA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 31. CANADA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 32. CANADA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 33. MEXICO CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 34. MEXICO CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 35. MEXICO CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 36. EUROPE CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 37. EUROPE CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
- TABLE 38. EUROPE CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 39. EUROPE CORONARY STENTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 40. GERMANY CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 41. GERMANY CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 42. GERMANY CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 43. FRANCE CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 44. FRANCE CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 45. FRANCE CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 46. U.K. CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 47. U.K. CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 48. U.K. CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 49. ITALY CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 50. ITALY CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 51. ITALY CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 52. SPAIN CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 53. SPAIN CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 54. SPAIN CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 55. REST OF LAMEA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 56. REST OF LAMEA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 57. REST OF LAMEA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 58. ASIA-PACIFIC CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 59. ASIA-PACIFIC CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
- TABLE 60. ASIA-PACIFIC CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 61. ASIA-PACIFIC CORONARY STENTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 62. CHINA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 63. CHINA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 64. CHINA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 65. JAPAN CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 66. JAPAN CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 67. JAPAN CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 68. INDIA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 69. INDIA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 70. INDIA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 71. AUSTRALIA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 72. AUSTRALIA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 73. AUSTRALIA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 74. SOUTH KOREA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 75. SOUTH KOREA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 76. SOUTH KOREA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 77. REST OF LAMEA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 78. REST OF LAMEA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 79. REST OF LAMEA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 80. LAMEA CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 81. LAMEA CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
- TABLE 82. LAMEA CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 83. LAMEA CORONARY STENTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 84. BRAZIL CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 85. BRAZIL CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 86. BRAZIL CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 87. SAUDI ARABIA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 88. SAUDI ARABIA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 89. SAUDI ARABIA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 90. SOUTH AFRICA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 91. SOUTH AFRICA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 92. SOUTH AFRICA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 93. REST OF LAMEA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 94. REST OF LAMEA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
- TABLE 95. REST OF LAMEA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
- TABLE 96.ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 97.ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 98.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 99.ABBOTT LABORATORIES: NET SALES,
- TABLE 100.ABBOTT LABORATORIES: KEY STRATERGIES
- TABLE 101.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
- TABLE 102.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
- TABLE 103.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
- TABLE 104.B. BRAUN MELSUNGEN AG: NET SALES,
- TABLE 105.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
- TABLE 106.BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
- TABLE 107.BIOTRONIK SE & CO. KG: OPERATING SEGMENTS
- TABLE 108.BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
- TABLE 109.BIOTRONIK SE & CO. KG: NET SALES,
- TABLE 110.BIOTRONIK SE & CO. KG: KEY STRATERGIES
- TABLE 111.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 112.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 113.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 114.BOSTON SCIENTIFIC CORPORATION: NET SALES,
- TABLE 115.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
- TABLE 116.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 117.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
- TABLE 118.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 119.BECTON, DICKINSON AND COMPANY: NET SALES,
- TABLE 120.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
- TABLE 121.ELIXIR MEDICAL CORPORATION: COMPANY SNAPSHOT
- TABLE 122.ELIXIR MEDICAL CORPORATION: OPERATING SEGMENTS
- TABLE 123.ELIXIR MEDICAL CORPORATION: PRODUCT PORTFOLIO
- TABLE 124.ELIXIR MEDICAL CORPORATION: NET SALES,
- TABLE 125.ELIXIR MEDICAL CORPORATION: KEY STRATERGIES
- TABLE 126.MEDTRONIC PLC.: COMPANY SNAPSHOT
- TABLE 127.MEDTRONIC PLC.: OPERATING SEGMENTS
- TABLE 128.MEDTRONIC PLC.: PRODUCT PORTFOLIO
- TABLE 129.MEDTRONIC PLC.: NET SALES,
- TABLE 130.MEDTRONIC PLC.: KEY STRATERGIES
- TABLE 131.MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 132.MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 133.MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 134.MICROPORT SCIENTIFIC CORPORATION: NET SALES,
- TABLE 135.MICROPORT SCIENTIFIC CORPORATION: KEY STRATERGIES
- TABLE 136.BIOSENSORS INTERNATIONAL GROUP: COMPANY SNAPSHOT
- TABLE 137.BIOSENSORS INTERNATIONAL GROUP: OPERATING SEGMENTS
- TABLE 138.BIOSENSORS INTERNATIONAL GROUP: PRODUCT PORTFOLIO
- TABLE 139.BIOSENSORS INTERNATIONAL GROUP: NET SALES,
- TABLE 140.BIOSENSORS INTERNATIONAL GROUP: KEY STRATERGIES
- TABLE 141.TERUMO CORPORATION: COMPANY SNAPSHOT
- TABLE 142.TERUMO CORPORATION: OPERATING SEGMENTS
- TABLE 143.TERUMO CORPORATION: PRODUCT PORTFOLIO
- TABLE 144.TERUMO CORPORATION: NET SALES,
- TABLE 145.TERUMO CORPORATION: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.CORONARY STENTS MARKET SEGMENTATION
- FIGURE 2.CORONARY STENTS MARKET,2020-2030
- FIGURE 3.CORONARY STENTS MARKET,2020-2030
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.CORONARY STENTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 11.CORONARY STENTS MARKET,BY TYPE,2020(%)
- FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DRUG-ELUTING STENTS CORONARY STENTS MARKET,2020-2030(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF BARE-METAL CORONARY STENTS CORONARY STENTS MARKET,2020-2030(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF BIOABSORBABLE STENTS CORONARY STENTS MARKET,2020-2030(%)
- FIGURE 15.CORONARY STENTS MARKET,BY BIOMATERIAL,2020(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF METALLIC BIOMATERIALS CORONARY STENTS MARKET,2020-2030(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF POLYMERS BIOMATERIALS CORONARY STENTS MARKET,2020-2030(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF NATURAL BIOMATERIALS CORONARY STENTS MARKET,2020-2030(%)
- FIGURE 19.CORONARY STENTS MARKET,BY END USER,2020(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HOSPITALS CORONARY STENTS MARKET,2020-2030(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS CORONARY STENTS MARKET,2020-2030(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF OTHER CORONARY STENTS MARKET,2020-2030(%)
- FIGURE 23.CORONARY STENTS MARKET BY REGION,2020
- FIGURE 24.U.S. CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 25.CANADA CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 26.MEXICO CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 27.GERMANY CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 28.FRANCE CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 29.U.K. CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 30.ITALY CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 31.SPAIN CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 32.REST OF LAMEA CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 33.CHINA CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 34.JAPAN CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 35.INDIA CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 36.AUSTRALIA CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 37.SOUTH KOREA CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 38.REST OF LAMEA CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 39.BRAZIL CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 40.SAUDI ARABIA CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 41.SOUTH AFRICA CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 42.REST OF LAMEA CORONARY STENTS MARKET,2020-2030($MILLION)
- FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 46.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 47.COMPETITIVE DASHBOARD
- FIGURE 48.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 49.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
- FIGURE 50.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)
- FIGURE 51.BIOTRONIK SE & CO. KG.: NET SALES ,($MILLION)
- FIGURE 52.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
- FIGURE 53.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)
- FIGURE 54.ELIXIR MEDICAL CORPORATION.: NET SALES ,($MILLION)
- FIGURE 55.MEDTRONIC PLC..: NET SALES ,($MILLION)
- FIGURE 56.MICROPORT SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
- FIGURE 57.BIOSENSORS INTERNATIONAL GROUP.: NET SALES ,($MILLION)
- FIGURE 58.TERUMO CORPORATION.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook